- Home
- NVCR vs HTFL Comparison
NVCR vs HTFL Comparison
Compare NVCR & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCR | HTFL |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NVCR | HTFL |
|---|---|---|
| Price | $17.73 | $47.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $28.08 | ★ $38.20 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.79 | ★ 82.37 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $655,353,000.00 | $176,034,000.00 |
| Revenue This Year | $7.72 | $27.66 |
| Revenue Next Year | $6.74 | $23.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.28 | ★ 39.92 |
| 52 Week Low | $9.82 | $20.13 |
| 52 Week High | $21.45 | $51.19 |
Technical Indicators
Market Signals| Indicator | NVCR | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 55.67 | 79.23 |
| Support Level | $14.84 | $22.96 |
| Resistance Level | $18.41 | N/A |
| Average True Range (ATR) | 0.74 | 2.60 |
| MACD | 0.06 | 0.92 |
| Stochastic Oscillator | 66.01 | 86.42 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.